MW3882A1 - Pharmaceutical formulations comprising human insulin human c-peptide - Google Patents
Pharmaceutical formulations comprising human insulin human c-peptideInfo
- Publication number
- MW3882A1 MW3882A1 MW38/82A MW3882A MW3882A1 MW 3882 A1 MW3882 A1 MW 3882A1 MW 38/82 A MW38/82 A MW 38/82A MW 3882 A MW3882 A MW 3882A MW 3882 A1 MW3882 A1 MW 3882A1
- Authority
- MW
- MALAWI
- Prior art keywords
- human
- peptide
- pharmaceutical formulations
- human insulin
- insulin human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29671581A | 1981-08-27 | 1981-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW3882A1 true MW3882A1 (en) | 1984-07-11 |
Family
ID=23143238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW38/82A MW3882A1 (en) | 1981-08-27 | 1982-08-24 | Pharmaceutical formulations comprising human insulin human c-peptide |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5846024A (fr) |
| AU (1) | AU551879B2 (fr) |
| BE (1) | BE894185A (fr) |
| CA (1) | CA1176158A (fr) |
| CH (1) | CH650679A5 (fr) |
| DE (1) | DE3232034A1 (fr) |
| DZ (1) | DZ452A1 (fr) |
| FR (1) | FR2513126B1 (fr) |
| GB (1) | GB2104382B (fr) |
| IE (1) | IE54119B1 (fr) |
| IL (1) | IL66611A0 (fr) |
| IT (1) | IT1153182B (fr) |
| LU (1) | LU84359A1 (fr) |
| MW (1) | MW3882A1 (fr) |
| NL (1) | NL192192C (fr) |
| NZ (1) | NZ201682A (fr) |
| PH (1) | PH19361A (fr) |
| SE (1) | SE460334B (fr) |
| ZA (1) | ZA826159B (fr) |
| ZW (1) | ZW17482A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| WO1988002633A1 (fr) * | 1986-10-20 | 1988-04-21 | Novo Industri A/S | Preparatiosn d'insuline avec du zinc et des protamines |
| CA1296253C (fr) * | 1986-10-20 | 1992-02-25 | Praveen Tyle | Compositions d'hormones de croissance stabilisees |
| ES2053723T3 (es) * | 1987-02-25 | 1994-08-01 | Novo Nordisk As | Nuevos derivados de insulina. |
| US5212154A (en) * | 1987-08-14 | 1993-05-18 | Akzo N.V. | Preparation for treating complications in diabetes |
| DE3863027D1 (de) * | 1987-08-14 | 1991-07-04 | Akzo Nv | Praeparat zur verhuetung oder bekaempfung von komplikationen bei diabetes. |
| SE520392C2 (sv) | 1996-09-27 | 2003-07-01 | Creative Peptides Sweden Ab C | Specifika peptider för behandling av diabetes mellitus |
| GB0323979D0 (en) | 2003-10-13 | 2003-11-19 | Creative Peptides Sweden Ab | Therapeutic applications for c-peptide |
| JP4874989B2 (ja) * | 2004-11-22 | 2012-02-15 | ノヴォ ノルディスク アー／エス | 可溶性で安定なインスリン含有調合物 |
| GB0511269D0 (en) | 2005-06-02 | 2005-07-13 | Creative Peptides Sweden Ab | Sustained release preparation of pro-insulin C-peptide |
| GB0601950D0 (en) * | 2006-01-31 | 2006-03-15 | Creative Peptides Sweden Ab | Compositions and methods of treating diabetes |
| EP2350118B1 (fr) | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Polymères à base de glucide pour administration de médicaments et leurs conjugués |
| JP2013533217A (ja) * | 2010-05-17 | 2013-08-22 | セビックス・インコーポレイテッド | Ｐｅｇ化ｃ−ペプチド |
| US8962553B2 (en) | 2011-11-17 | 2015-02-24 | Cebix Ab | Method of treating a diabetic subject having a microvascular impairment disorder by a pegylated C-peptide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789080A (en) * | 1952-08-14 | 1957-04-16 | Christensen Henry Marinus | Insulin-albumin compositions |
| CH330318A (de) * | 1953-09-08 | 1958-05-31 | British Drug Houses Ltd | Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit |
-
1982
- 1982-08-23 IL IL66611A patent/IL66611A0/xx unknown
- 1982-08-23 CH CH5010/82A patent/CH650679A5/de not_active IP Right Cessation
- 1982-08-23 ZW ZW174/82A patent/ZW17482A1/xx unknown
- 1982-08-23 CA CA000409900A patent/CA1176158A/fr not_active Expired
- 1982-08-24 NZ NZ201682A patent/NZ201682A/en unknown
- 1982-08-24 BE BE6/47701A patent/BE894185A/fr not_active IP Right Cessation
- 1982-08-24 MW MW38/82A patent/MW3882A1/xx unknown
- 1982-08-24 ZA ZA826159A patent/ZA826159B/xx unknown
- 1982-08-24 PH PH27772A patent/PH19361A/en unknown
- 1982-08-24 DZ DZ826637A patent/DZ452A1/fr active
- 1982-08-24 NL NL8203315A patent/NL192192C/nl not_active IP Right Cessation
- 1982-08-25 JP JP57148494A patent/JPS5846024A/ja active Pending
- 1982-08-25 AU AU87594/82A patent/AU551879B2/en not_active Expired
- 1982-08-25 SE SE8204873A patent/SE460334B/sv not_active IP Right Cessation
- 1982-08-25 FR FR8214595A patent/FR2513126B1/fr not_active Expired
- 1982-08-26 GB GB08224484A patent/GB2104382B/en not_active Expired
- 1982-08-26 LU LU84359A patent/LU84359A1/fr unknown
- 1982-08-26 IE IE2064/82A patent/IE54119B1/en not_active IP Right Cessation
- 1982-08-27 IT IT8223017A patent/IT1153182B/it active
- 1982-08-27 DE DE19823232034 patent/DE3232034A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NL192192C (nl) | 1997-03-04 |
| ZW17482A1 (en) | 1982-11-17 |
| AU8759482A (en) | 1983-03-03 |
| LU84359A1 (fr) | 1983-02-28 |
| SE460334B (sv) | 1989-10-02 |
| ZA826159B (en) | 1984-04-25 |
| FR2513126B1 (fr) | 1986-04-18 |
| NL192192B (nl) | 1996-11-01 |
| IT8223017A0 (it) | 1982-08-27 |
| NZ201682A (en) | 1985-08-16 |
| IL66611A0 (en) | 1982-12-31 |
| CH650679A5 (de) | 1985-08-15 |
| FR2513126A1 (fr) | 1983-03-25 |
| IE822064L (en) | 1983-02-27 |
| DE3232034C2 (fr) | 1991-04-11 |
| JPS5846024A (ja) | 1983-03-17 |
| SE8204873L (sv) | 1983-02-28 |
| CA1176158A (fr) | 1984-10-16 |
| PH19361A (en) | 1986-04-02 |
| BE894185A (fr) | 1983-02-24 |
| DZ452A1 (fr) | 2004-09-13 |
| IT8223017A1 (it) | 1984-02-27 |
| GB2104382B (en) | 1984-12-19 |
| DE3232034A1 (de) | 1983-03-10 |
| AU551879B2 (en) | 1986-05-15 |
| GB2104382A (en) | 1983-03-09 |
| IT1153182B (it) | 1987-01-14 |
| IE54119B1 (en) | 1989-06-21 |
| SE8204873D0 (sv) | 1982-08-25 |
| NL8203315A (nl) | 1983-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3264782D1 (en) | Medicinal formulation | |
| AU551733B2 (en) | Human insulin and human proinsulin formulations | |
| AU549066B2 (en) | Preparation of human insulin | |
| GB2104382B (en) | Pharmaceutical formulations comprising human insulin and human c-peptide | |
| ZA824513B (en) | Pharmaceutical formulations | |
| GB8311420D0 (en) | Insulin formulations | |
| GB2104380B (en) | Human proinsulin pharmaceutical formulations | |
| AU551734B2 (en) | Human proinsulin and human c-peptide and human insulin formulations | |
| IE812104L (en) | Novel insulin formulations based on human insulin | |
| IE822065L (en) | Insulin and proinsulin formulations | |
| JO1238B1 (en) | Pharmacy formulations include human insulin, human peptide-C and the human insulin component |